Anti-tumor activity of oxypeucedanin from Ostericum koreanum against human prostate carcinoma DU145 cells

Acta Oncologica

Volumn 48, Issue 6, 2009, Pages 895-900

  Kang, Tae Jin ^a   Lee, Sook Yeon ^a   Singh, Rana P ^b   Agarwal, Rajesh ^b   Yim, Dong Sool ^a  

^a Sahmyook University   (South Korea)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; COUMARIN DERIVATIVE; CYCLIN A; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OXYPEUCEDANIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APIALES; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL DEATH; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVATION; GEL CHROMATOGRAPHY; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE; OSTERICUM KOREANUM; PRIORITY JOURNAL; PROSTATE CARCINOMA; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APIACEAE; APOPTOSIS; CASPASE 3; CELL DIVISION; CELL PROLIFERATION; CYCLINS; G2 PHASE; HUMANS; IMMUNOBLOTTING; MALE; PLANT ROOTS; POLY(ADP-RIBOSE) POLYMERASES; PROSTATIC NEOPLASMS; PSORALENS; TUMOR CELLS, CULTURED;

EID: 70350664657     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860902824925     Document Type: Article

References (25)

1. Wall ME, Wani MC, Manikumar G, Hughes TJ, Taylor H, McGivney R, et al. Plant antimutagenic agents, 3. Coumarins. J Nat Prod 1988;/51:/1148-52.
2. Cai Y, Baer-Dubowska W, Ashwood-Smith M, DiGiovanni J. Inhibitory effects of naturally occurring coumarins on the metabolic activation of benzo[a]pyrene and 7,12-dimethylbenz[ a]anthracene in cultured mouse keratinocytes. Carcinogenesis 1997;/18:/215-22.
3. Chi HJ, Kim HS. Pharmacological study of isoimperatorin and oxypeucedanin. Kor J Pharmac 1970;/14:/21-7.
4. Oh H, Lee HS, Kim TW, Chai KY, Chung HT, Kwon TO, et al. Furocoumarins from Angelica dahurica with hepatoprotective activity on tacrine-induced cytotoxicity in Hep G2 cells. Planta Med 2002;/68:/463-4. (Pubitemid 34606695)
5. Kang JY, Lee SY, Yim DS. Effect of isoimperatorin on the proliferation of prostate cancer cell line du145 cells. J Appl Pharmacol 2005;/13:/185-9.
6. Denmeade SR, Isaacs JT. A history of prostate cancer treatment. Nat Rev Cancer 2002;/2:/389-96.
7. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;/55:/10-30.
8. Nelson WG, De Marzo AM, Deweese TL, Lin X, Brooks JD, Putzi MJ, et al. Preneoplastic prostate lesions: An opportunity for prostate cancer prevention. Ann NY Acad Sci 2001;/952:/135-44.
9. De Marzo AM, Meeker AK, Zha S, Luo J, Nakayama M, Platz EA, et al. Human prostate cancer precursors and pathobiology. Urology 2003;/62:/55-62.
10. Godley PA, Campbell MK, Gallagher P, Martinson FEA, Mohler JL, Sandler RS. Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemol Biomark Prev 1996;/5:/889-95.
11. Ross RK, Henderson BE. Do diet and androgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst 1994;/86:/252-4.
12. Baek NI, Ahn Em, Kim HY, Park YD. Furanocoumarins from the root of Angelica dahurica. Arch Pharm Res 2000;/ 23:/467-70.
13. Tyagi A, Bhatia N, Condon MS, Bosland MC, Agarwal C, Agarwal R. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells. Prostate 2002;/53:/211-7.
14. Singh RP, Agrawal P, Yim D, Agarwal C, Agarwal R. Acacetin inhibits cell growth and cell cycle progression and induces apoptosis in human prostate cancer cells. Structureactivity relationship with linarin and linarin acetate Carcinogenesis 2005;/26:/845-54.
15. Grana X, Reddy EP. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995;/11:/211-9.
16. Singh RP, Dhanalakshmi S, Agarwal R. Phytochemicals as cell cycle modulators-a less toxic approach in halting human cancers. Cell Cycle 2002;/1:/156-61.
17. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000;/21:/485-95.
18. Lee YY, Lee S, Jin JL, Yun-Choi HS. Platelet antiaggregatory effects of coumarins from the roots of Angelica genuflexa and A. gigas. Arch Pharm Res 2003;/26:/723-6.
19. Kim YK, Kim YS, Ryu SY. Antiproliferative effect of furanocoumarins from the root of Angelica dahurica on cultured human tumor cell lines. Phytother Res 2007;/21:/ 288-90.
20. Kim CM, Heo MY, Kim HP, Sin KS, Pachaly P. Pharmacological activities of water extracts of Umbelliferae plants. Arch Pharm Res 1991;/14:/87-92.
21. Yuan J, Yan R, Kramer A, Eckerdt F, Roller M, Kaufmann M, et al. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene 2004;/23:/ 5843-52.
22. Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM, et al. The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem 2000;/275:/5600-5.
23. Gurumurthy S, Vasudevan KM, Rangnekar VM. Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev 2001;/ 20:/225-43.
24. Pilat MJ, Kamradt JM, Pienta KJ. Hormone resistance in prostate cancer. Cancer Metastasis 1998-1998;/17:/373-81.
25. Kantoff PW. New agents in the therapy of hormonerefractory patients with prostate cancer. Semin Oncol 1995;/22:/32-4.